Hypothetical $10,000 invested at their first disclosed trade date. · log scale
Hypothetical backtest based on disclosed trades. Past performance does not predict future results. Not investment advice.
| Ticker | Action | Description | Traded |
|---|---|---|---|
| PODD | Sell | Insulet Corporation | May 7, 2026 |
| DXCM | Sell | DexCom, Inc. | May 7, 2026 |
| PODD | Sell | Insulet Corporation | Apr 29, 2026 |
| DXCM | Sell | DexCom, Inc. | Apr 29, 2026 |
| MMM | Sell | 3M Company Common Stock | Mar 31, 2026 |
| BRK.B | Sell | Berkshire Hathaway Inc. New | Mar 31, 2026 |
| BRK.B | Sell | Berkshire Hathaway Cl B | Jan 27, 2026 |
| MMC | Sell | MRSH | Jan 27, 2026 |
| HBAN | Sell | Huntington Bancshares Incorp | Nov 21, 2025 |
| PEP | Sell | PepsiCo, Inc. | Feb 11, 2025 |
Tina Smith is a United States Senator from MN affiliated with the Democratic Party, serving in the US Senate. Disclosed Capitol tracks 42 disclosed stock trades from Tina Smith, filed under the STOCK Act. The portfolio compounds at 12.0% annualized — 0.0% above the S&P 500 benchmark over the same period, with a 44% win rate on individual trades. The full trade history, holdings, sector allocation, and risk metrics are below.
Tina Smith (D-MN) has disclosed 42 trades under the STOCK Act; portfolio CAGR of 12.0% (+0.0% vs. the S&P 500); top tickers traded: PODD, N/A, TCMD.
Full trade list with transaction dates, disclosure dates, tickers, and amount ranges is in the interactive table below.
Most-traded tickers: PODD, N/A, TCMD. Sector allocation and portfolio weighting appear in the Holdings panel.
Annualized return: 12.0% CAGR, +0.0% alpha vs. the S&P 500. Detailed performance charts are in the Performance panel.
Tina Smith's disclosed stock portfolio is valued at approximately $1.6M across 3 tracked positions. This reflects only publicly disclosed, exchange-traded securities from STOCK Act filings — it excludes real estate, private assets, cash, and liabilities, so it is a partial floor on Tina Smith's total net worth, not a complete measure of it.